Sign in

CIK 0001815776 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company

LENZ Therapeutics, Inc.

Sign in to watch
Ticker
LENZ
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
844867570
Phone
858-925-7000
Business address
201 LOMAS SANTA FE DRIVE, SUITE 300, SOLANA BEACH, CA, 92075
Former names
Graphite Bio, Inc.
  1. 424B3 Offering Prospectus
  2. 10-Q Report Quarterly Report
  3. 8-K Event Results of operations
  4. 424B3 Offering Prospectus
  5. 424B3 Offering Prospectus
  6. 8-K Event Other events
  7. EFFECT Other Notice of Effectiveness
  8. 424B3 Offering Prospectus
  9. CORRESP Other Correspondence Between Filers and SEC Staff
  10. UPLOAD Other SEC-generated Letter
  11. S-1 Offering Registration Statement
  12. 424B3 Offering Prospectus
  13. 10-Q Report Quarterly Report
  14. 8-K Event Results of operations
  15. 424B3 Offering Prospectus
  16. 8-K Event Other events
  17. SC 13G Stake Amended Statement of Ownership
  18. 4 Insider Changes in Ownership
  19. 424B3 Offering Prospectus
  20. 8-K Event Material agreement · Unregistered share sale · Regulation FD disclosure

Page 7 of 18 · 359 filings